Aurobindo Pharma Limited is delighted to announce that the USFDA has approved its product, "MELOXICAM 7.5mg and15mg Tablets". Meloxicam is a NSAID (Non steroidal anti-inflammatory and analgesic) normally used to reduce pain, tenderness, swelling, fever and stiffness of joints associated with arthritis and various other conditions where inflammatory component is involved.
Aurobindo manufactures Meloxicam API and Formulations.
Meloxicam is effective in low therapeutic doses in comparison to many other drugs of its class. It belongs to Enolic acid group. Meloxicam is a generic version of Mobic, a product of "Boehringer Ingelheim". Meloxicam is one of the top selling molecules in its therapeutic group. This approval enables Aurobindo to participate in a market of over a billion USD.
